Ads
related to: vertex pharmaceuticals- Careers
Join our Mission to Improve
the Lives of Patients.
- Pipeline
Review our Pipeline and
See How We're Changing Treatment.
- About Us
Discover the Unique Approach
That Makes Genmab Different.
- Sign Up
Sign Up for Updates, News
and Much More.
- Approved Medicines
See the Approved Treatments
Using Our Antibody Science.
- Antibody Science
Explore Our Unique Platforms
For Creating Antibody Treatments.
- Careers
Search results
Insider Sale: EVP and CMO Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
GuruFocus.com via Yahoo Finance· 3 days agoOn May 29, 2024, Carmen Bozic, Executive Vice President and Chief Medical Officer of Vertex ...
Insider Sale: EVP and CMO Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX) By...
Investing.com· 3 days agoThe transaction was executed at a price of $445.56 per share, as detailed in the SEC Filing....
3 No-Brainer Stocks to Buy in June | The Motley Fool
The Motley Fool· 2 days agoYou're probably familiar with the old adage, "April showers bring May flowers." Here's why they picked AbbVie (ABBV 3.15%), AstraZeneca (AZN 1.63%), and ...
Insider Sale: EVP & CFO Charles F. Wagner Jr. Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
GuruFocus.com via Yahoo Finance· 4 days agoOn May 28, 2024, Charles F. Wagner Jr., Executive Vice President and Chief Financial Officer of ...
Insider Sale: EVP & CFO Charles F. Wagner Jr. Sells Shares of Vertex Pharmaceuticals Inc (VRTX) By...
Investing.com· 4 days agoThe transaction was executed at a price of $454.79 per share, as detailed in the SEC Filing....
Why Vertex Pharmaceuticals (VRTX) is a Top Growth Stock for the Long-Term
Zacks via Yahoo Finance· 4 days agoThis Score examines things like projected and historical earnings, sales, and cash flow to find...
Unveiling Vertex Pharmaceuticals (VRTX)'s Value: Is It Really Pr
Guru Focus· 6 days agoVertex Pharmaceuticals Inc (VRTX, Financial) recently noted a daily loss of 2.23%, yet it maintains a 3-month gain of 4.7%. This article delves into the ...
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals? | The Motley Fool
The Motley Fool· 5 days agoIf you own shares of Abbott (ABT 0.44%) or DexCom (DXCM 0.31%), there's a looming threat to know...
3 No-Brainer Stocks to Buy in June
Motley Fool via Yahoo Finance· 2 days agoHere's why they picked AbbVie (NYSE: ABBV), AstraZeneca (NASDAQ: AZN), and Vertex Pharmaceuticals (NASDAQ: VRTX) as no-brainer stocks to buy in June....
5 Top Stocks to Buy in June
Motley Fool via Yahoo Finance· 2 days agoThese Motley Fool contributors are particularly excited about SoundHound AI (NASDAQ: SOUN), Adobe (NASDAQ: ADBE), Vertex Pharmaceuticals (NASDAQ: VRTX),...
